Potential impact of BMI on the aggressiveness of presentation and clinical outcome of differentiated thyroid cancer
Journal of Clinical Endocrinology and Metabolism Jan 06, 2020
Matrone A, Ceccarini G, Beghini M, et al. - One thousand fifty-eight consecutive differentiated thyroid cancer (DTC) individuals treated with total thyroidectomy and registered at the time of the first 131I treatment were assessed in order to explore the connection between BMI, DTC aggressiveness at the diagnosis and clinical result. Based on their BMI, study participants were divided into four groups: underweight (< 18.5 kg/m2), normal weight (18.5-24.9 kg/m2), overweight (25-29.9 kg/m2) and obese (≥ 30 kg/m2). According to results, no link was found between BMI and DTC aggressiveness in the study group of Caucasian individuals, either at the time of diagnosis or during follow-up. Such findings suggest that postsurgical evaluation and therapeutic attitude for treatment and follow-up of DTC should be based on the risk class applied to the general population, with no concern for BMI.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries